Benlot, Oscar B.

HRN: 29-02-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/21/2026
05/28/2026
IV
500mg
Q8H
T/C Early Post-op Adhesions; S/P Inguinal Exploration, Bilateral, Mesh Hernioplasty (5/18/26)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: